Skip to content
PubMed This is a summary of 106 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 106 referenced papers

Top Authors

Hann‐Chorng Kuo
Tzu Chi University
Jia‐Fong Jhang
Tzu Chi University
H. Henry Lai
Washington University in St. Louis
Yuan‐Hong Jiang
Tzu Chi University
Wan‐Ru Yu
Tzu Chi University
Yoshiyuki Akiyama
Shinshu University
J. Quentin Clemens
University of Michigan
Robert Moldwin
Hofstra University
Jennifer T. Anger
University of California San Diego
A. Lenore Ackerman
University of California, Los Angeles

Top Institutions

Ranked by publications Top 10 institutions
06
08

Hofstra University

Hempstead, United States

17 papers

References

References (106)
  1. 1

    Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.

    Gao Y, Liao L

    International urogynecology journal 2015; (26(7)):1021-6 doi:10.1007/s00192-015-2631-y.

    PMID: 25690160
  2. 2

    Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms.

    Scott VC, Haake DA, Churchill BM, et al.

    Urology 2015; (86(3)):425-31.

    PMID: 26189137
  3. 3

    Are High Proanthocyanidins Key to Cranberry Efficacy in the Prevention of Recurrent Urinary Tract Infection?

    Vostalova J, Vidlar A, Simanek V, et al.

    Phytotherapy research : PTR 2015; (29(10)):1559-67 doi:10.1002/ptr.5427.

    PMID: 26268913
  4. 4

    Management of Benign Prostatic Hyperplasia.

    Kim EH, Larson JA, Andriole GL

    Annual review of medicine 2016; (67()):137-51 doi:10.1146/annurev-med-063014-123902.

    PMID: 26331999
  5. 5

    Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis.

    Jiang YH, Jhang JF, Kuo HC

    PloS one 2016; (11(3)):e0151692 doi:10.1371/journal.pone.0151692.

    PMID: 26999787
  6. 6

    Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.

    Price JR, Guran LA, Gregory WT, McDonagh MS

    American journal of obstetrics and gynecology 2016; (215(5)):548-560 doi:10.1016/j.ajog.2016.07.040.

    PMID: 27457111
  7. 7

    AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.

    Stoffel JT, Peterson AC, Sandhu JS, et al.

    The Journal of urology 2017; (198(1)):153-160 doi:10.1016/j.juro.2017.01.075.

    PMID: 28163030
  8. 8

    The therapeutic approach to different forms of cystitis: impact on public health.

    Droupy S

    Urologia 2017; (84(Suppl 1)):8-15 doi:10.5301/uj.5000262.

    PMID: 28862726
  9. 9

    No. 250-Recurrent Urinary Tract Infection.

    Epp A, Larochelle A

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2017; (39(10)):e422-e431 doi:10.1016/j.jogc.2017.08.017.

    PMID: 28935065
  10. 10

    A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network.

    Sutcliffe S, Jemielita T, Lai HH, et al.

    The Journal of urology 2018; (199(5)):1245-1251 doi:10.1016/j.juro.2017.12.050.

    PMID: 29288643
  11. 11

    Urodynamic observations and lower urinary tract symptoms associated with endometriosis: a prospective cross-sectional observational study assessing women with deep infiltrating disease.

    de Resende Júnior JAD, Crispi CP, Cardeman L, et al.

    International urogynecology journal 2018; (29(9)):1349-1358 doi:10.1007/s00192-017-3531-0.

    PMID: 29313088
  12. 12

    The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention.

    Kranz J, Schmidt S, Lebert C, et al.

    Urologia internationalis 2018; (100(3)):271-278 doi:10.1159/000487645.

    PMID: 29539622
  13. 13

    Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?

    Tan WS, Sarpong R, Khetrapal P, et al.

    The Journal of urology 2018; (200(5)):973-980 doi:10.1016/j.juro.2018.04.065.

    PMID: 29702097
  14. 14

    Treatment and Prevention of Recurrent Lower Urinary Tract Infections in Women: A Rapid Review with Practice Recommendations.

    Smith AL, Brown J, Wyman JF, et al.

    The Journal of urology 2018; (200(6)):1174-1191 doi:10.1016/j.juro.2018.04.088.

    PMID: 29940246
  15. 15

    Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis.

    Selekman RE, Shapiro DJ, Boscardin J, et al.

    Pediatrics 2018; (142(1)) doi:10.1542/peds.2018-0119.

    PMID: 29954832
  16. 16

    Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.

    Fisher H, Oluboyede Y, Chadwick T, et al.

    The Lancet. Infectious diseases 2018; (18(9)):957-968 doi:10.1016/S1473-3099(18)30279-2.

    PMID: 30037647
  17. 17

    Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.

    Nik-Ahd F, Lenore Ackerman A, Anger J

    Current urology reports 2018; (19(11)):94 doi:10.1007/s11934-018-0839-3.

    PMID: 30215140
  18. 18

    Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.

    Ackerman AL, Lai HH, Parameshwar PS, et al.

    BJU international 2019; (123(4)):682-693 doi:10.1111/bju.14568.

    PMID: 30253040
  19. 19

    Urinary Retention in Adults: Evaluation and Initial Management.

    Serlin DC, Heidelbaugh JJ, Stoffel JT

    American family physician 2018; (98(8)):496-503.

    PMID: 30277739
  20. 20

    Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

    Acar Ö, Tarcan T

    Journal of the Turkish German Gynecological Association 2019; (20(2)):117-122 doi:10.4274/jtgga.galenos.2018.2018.0102.

    PMID: 30457110
  21. 21

    Pelvic floor myofascial pain in patients with symptoms of urinary tract infection.

    Wolff BJ, Joyce CJ, Brincat CA, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019; (145(2)):205-211 doi:10.1002/ijgo.12784.

    PMID: 30758844
  22. 22

    A Culture-Independent Analysis of the Microbiota of Female Interstitial Cystitis/Bladder Pain Syndrome Participants in the MAPP Research Network.

    Nickel JC, Stephens-Shields AJ, Landis JR, et al.

    Journal of clinical medicine 2019; (8(3)) doi:10.3390/jcm8030415.

    PMID: 30917614
  23. 23

    Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.

    Whitmore KE, Fall M, Sengiku A, et al.

    International journal of urology : official journal of the Japanese Urological Association 2019; (26 Suppl 1()):26-34 doi:10.1111/iju.13971.

    PMID: 31144757
  24. 24

    Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.

    Ferrante KL, Wasenda EJ, Jung CE, et al.

    Female pelvic medicine & reconstructive surgery 2021; (27(2)):112-117 doi:10.1097/SPV.0000000000000749.

    PMID: 31232721
  25. 25

    Advanced Management of Patients With Ulcerative Interstitial Cystitis/Bladder Pain Syndrome.

    Crescenze IM, Gupta P, Adams G, et al.

    Urology 2019; (133()):78-83 doi:10.1016/j.urology.2019.07.036.

    PMID: 31442473
  26. 26

    Latin American consensus on uncomplicated recurrent urinary tract infection-2018.

    Haddad JM, Ubertazzi E, Cabrera OS, et al.

    International urogynecology journal 2020; (31(1)):35-44 doi:10.1007/s00192-019-04079-5.

    PMID: 31494690
  27. 27

    Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.

    Jhang JF

    Toxins 2019; (11(11)) doi:10.3390/toxins11110641.

    PMID: 31689912
  28. 28

    Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial.

    Ko KJ, Cho WJ, Lee YS, et al.

    European urology 2020; (77(5)):644-651 doi:10.1016/j.eururo.2020.01.002.

    PMID: 31959549
  29. 29

    Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report.

    Fall M, Nordling J, Cervigni M, et al.

    Scandinavian journal of urology 2020; (54(2)):91-98 doi:10.1080/21681805.2020.1730948.

    PMID: 32107957
  30. 30

    Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.

    Lai HH, Pickersgill NA, Vetter JM

    The Journal of urology 2020; (204(3)):518-523 doi:10.1097/JU.0000000000001031.

    PMID: 32223699
  31. 31

    Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

    Akiyama Y, Luo Y, Hanno PM, et al.

    International journal of urology : official journal of the Japanese Urological Association 2020; (27(6)):491-503 doi:10.1111/iju.14229.

    PMID: 32246572
  32. 32

    Clinical guidelines for interstitial cystitis/bladder pain syndrome.

    Homma Y, Akiyama Y, Tomoe H, et al.

    International journal of urology : official journal of the Japanese Urological Association 2020; (27(7)):578-589 doi:10.1111/iju.14234.

    PMID: 32291805
  33. 33

    Correlates of 1-Year Change in Quality of Life in Patients with Urologic Chronic Pelvic Pain Syndrome: Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

    Clemens JQ, Stephens-Shields AJ, Newcomb C, et al.

    The Journal of urology 2020; (204(4)):754-759 doi:10.1097/JU.0000000000001080.

    PMID: 32294397
  34. 34

    Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women.

    de Rossi P, Cimerman S, Truzzi JC, et al.

    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2020; (24(2)):110-119 doi:10.1016/j.bjid.2020.04.002.

    PMID: 32360431
  35. 35

    Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.

    Chen YY, Su TH, Lau HH

    International urogynecology journal 2021; (32(1)):17-25 doi:10.1007/s00192-020-04397-z.

    PMID: 32564121
  36. 36

    Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.

    Jhang JF, Hsu YH, Jiang YH, et al.

    The Journal of urology 2021; (205(1)):226-235 doi:10.1097/JU.0000000000001334.

    PMID: 32856961
  37. 37

    Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy.

    Ronstrom C, Lai HH

    Neurourology and urodynamics 2020; (39(8)):2394-2400 doi:10.1002/nau.24500.

    PMID: 32902893
  38. 38

    New paradigms in the management of recurrent urinary tract infections.

    Taich L, Zhao H, Cordero C, Anger JT

    Current opinion in urology 2020; (30(6)):833-837 doi:10.1097/MOU.0000000000000823.

    PMID: 32941258
  39. 39

    Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.

    Paredes Mogica JA, De EJB

    Urology 2021; (147()):109-118 doi:10.1016/j.urology.2020.08.072.

    PMID: 33045286
  40. 40

    Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: A case-control study.

    Agrawal A, Tripathy S, Kumar D

    Indian journal of urology : IJU : journal of the Urological Society of India 2020; (36(3)):212-215 doi:10.4103/iju.IJU_145_20.

    PMID: 33082637
  41. 41

    Qualitative Analysis of Treatment Needs in Interstitial Cystitis/Bladder Pain Syndrome: Implications for Intervention.

    McKernan LC, Bonnet KR, Finn MTM, et al.

    Canadian journal of pain = Revue canadienne de la douleur 2020; (4(1)):181-198 doi:10.1080/24740527.2020.1785854.

    PMID: 33367196
  42. 42

    The Benefits and Harms of Antibiotic Prophylaxis for Urinary Tract Infection in Older Adults.

    Langford BJ, Brown KA, Diong C, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(3)):e782-e791 doi:10.1093/cid/ciab116.

    PMID: 33595621
  43. 43

    Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.

    Di XP, Luo DY, Jin X, et al.

    International urogynecology journal 2021; (32(5)):1129-1141 doi:10.1007/s00192-020-04659-w.

    PMID: 33638677
  44. 44

    High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial.

    Babar A, Moore L, Leblanc V, et al.

    BMC urology 2021; (21(1)):44 doi:10.1186/s12894-021-00811-w.

    PMID: 33757474
  45. 45

    Recurrent uncomplicated urinary tract infections: definitions and risk factors.

    Cai T

    GMS infectious diseases 2021; (9()):Doc03 doi:10.3205/id000072.

    PMID: 34113535
  46. 46

    Complicated urinary tract infection in patients with benign prostatic hyperplasia.

    Choi JB, Min SK

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2021; (27(9)):1284-1287 doi:10.1016/j.jiac.2021.06.006.

    PMID: 34144904
  47. 47

    Current standard of care in treatment of bladder pain syndrome/interstitial cystitis.

    Lopez SR, Mangır N

    Therapeutic advances in urology 2021; (13()):17562872211022478 doi:10.1177/17562872211022478.

    PMID: 34178118
  48. 48

    [Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome].

    Wang JW, Liu JC, Meng LF, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2021; (53(4)):653-658.

    PMID: 34393223
  49. 49

    Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.

    Lee YK, Jhang JF, Jiang YH, et al.

    Scientific reports 2021; (11(1)):17258 doi:10.1038/s41598-021-96810-w.

    PMID: 34446784
  50. 50

    The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.

    Chen Y, Ying Z, Xiao Y, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2021; (265()):156-161 doi:10.1016/j.ejogrb.2021.08.025.

    PMID: 34492610
  51. 51

    [Oral therapy for interstitial cystitis: pentosan polysulfate sodium].

    Wiedemann A

    Aktuelle Urologie 2021; (52(6)):556-560 doi:10.1055/a-1629-0199.

    PMID: 34583396
  52. 52

    Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.

    Lin HY, Lu JH, Chuang SM, et al.

    Diagnostics (Basel, Switzerland) 2021; (12(1)) doi:10.3390/diagnostics12010075.

    PMID: 35054241
  53. 53

    Bladder Ultrastructure and Urinary Cytokine Abnormality in Patients with Recurrent Urinary Tract Infection and the Changes after Intravesical Platelet-Rich Plasma Injections.

    Jhang JF, Ho HC, Hsu YH, et al.

    Biomedicines 2022; (10(2)) doi:10.3390/biomedicines10020245.

    PMID: 35203455
  54. 54

    Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.

    Harding C, Mossop H, Homer T, et al.

    BMJ (Clinical research ed.) 2022; (376()):e068229 doi:10.1136/bmj-2021-0068229.

    PMID: 35264408
  55. 55

    Is Pelvic Floor Muscle Tenderness a Distinct Urologic Chronic Pelvic Pain Syndrome Phenotype? Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Symptom Pattern Study.

    Gupta P, Gallop R, Spitznagle T, et al.

    The Journal of urology 2022; (208(2)):341-349 doi:10.1097/JU.0000000000002679.

    PMID: 35344391
  56. 56

    Comparing surgical interventions for interstitial cystitis: A systematic review.

    Abelleyra Lastoria DA, Raison N, Aydin A, et al.

    Lower urinary tract symptoms 2022; (14(4)):218-241 doi:10.1111/luts.12441.

    PMID: 35393778
  57. 57

    Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome.

    Chermansky CJ, Guirguis MO

    The Urologic clinics of North America 2022; (49(2)):273-282 doi:10.1016/j.ucl.2022.01.003.

    PMID: 35428433
  58. 58

    Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.

    Harding C, Chadwick T, Homer T, et al.

    Health technology assessment (Winchester, England) 2022; (26(23)):1-172 doi:10.3310/QOIZ6538.

    PMID: 35535708
  59. 59

    Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

    Clemens JQ, Erickson DR, Varela NP, Lai HH

    The Journal of urology 2022; (208(1)):34-42 doi:10.1097/JU.0000000000002756.

    PMID: 35536143
  60. 60

    Guideline of guidelines: management of recurrent urinary tract infections in women.

    Kwok M, McGeorge S, Mayer-Coverdale J, et al.

    BJU international 2022; (130 Suppl 3()):11-22 doi:10.1111/bju.15756.

    PMID: 35579121
  61. 61

    Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.

    Yu WR, Chang WC, Kuo HC

    International urology and nephrology 2022; (54(9)):2157-2165 doi:10.1007/s11255-022-03294-2.

    PMID: 35804206
  62. 62

    The impact of Hunner lesion-type interstitial cystitis/bladder pain syndrome on health-related quality of life and the effects of transurethral ablation.

    Ko KJ, Lim J, Yu J, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2022; (31(11)):3221-3228 doi:10.1007/s11136-022-03183-2.

    PMID: 35870044
  63. 63

    Antibiotics for Preventing Recurrent Urinary Tract Infection: Systematic Review and Meta-analysis.

    Jent P, Berger J, Kuhn A, et al.

    Open forum infectious diseases 2022; (9(7)):ofac327 doi:10.1093/ofid/ofac327.

    PMID: 35899289
  64. 64

    Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome.

    Jarman A, Janes JL, Shorter B, et al.

    The Journal of urology 2023; (209(1)):216-224 doi:10.1097/JU.0000000000002938.

    PMID: 36001744
  65. 65

    Bladder pain syndrome/interstitial cystitis response to nerve blocks and trigger point injections.

    Patil S, Daniel G, Tailor Y, et al.

    BJUI compass 2022; (3(6)):450-457 doi:10.1002/bco2.176.

    PMID: 36267200
  66. 66

    Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome-A Randomized Clinical Trial.

    Yu WR, Jhang JF, Chen BY, et al.

    Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206221.

    PMID: 36294541
  67. 67

    Current role of neuromodulation in bladder pain syndrome/interstitial cystitis.

    Padilla-Fernández B, Hernández-Hernández D, Castro-Díaz DM

    Therapeutic advances in urology 2022; (14()):17562872221135941 doi:10.1177/17562872221135941.

    PMID: 36438605
  68. 68

    Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome.

    Mu HY, Wu MP, Wang IT, et al.

    Medicine 2023; (102(6)):e32790 doi:10.1097/MD.0000000000032790.

    PMID: 36820564
  69. 69

    Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.

    Ackerman AL, Jackson NJ, Caron AT, et al.

    medRxiv : the preprint server for health sciences 2023; doi:10.1101/2023.04.14.23288590.

    PMID: 37131628
  70. 70

    The Interstitial Cystitis/Bladder Pain Syndrome Clinical Picture: A Perspective from Patient Life Experience.

    Nickel JC, Tripp DA, Beiko D, et al.

    Urology practice 2018; (5(4)):286-292 doi:10.1016/j.urpr.2017.06.005.

    PMID: 37312294
  71. 71

    Nutritional Considerations for Bladder Storage Conditions in Adult Females.

    Gordon B

    International journal of environmental research and public health 2023; (20(19)) doi:10.3390/ijerph20196879.

    PMID: 37835149
  72. 72

    Current position of neuromodulation for bladder pain syndrome/interstitial cystitis.

    Kendall HJ, Schrijvers J, Heesakkers JPFA

    Current opinion in urology 2024; (34(2)):64-68 doi:10.1097/MOU.0000000000001148.

    PMID: 37933670
  73. 73

    Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan.

    Yu WR, Kuo HC

    Lower urinary tract symptoms 2024; (16(1)):e12508 doi:10.1111/luts.12508.

    PMID: 37987028
  74. 74

    Believing women: a qualitative exploration of provider disbelief and pain dismissal among women with interstitial cystitis/bladder pain syndrome from the MAPP research network.

    Brown VL, James A, Hunleth J, et al.

    International urogynecology journal 2024; (35(1)):139-148 doi:10.1007/s00192-023-05677-0.

    PMID: 37991567
  75. 75

    Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-Analysis of the Peer-Reviewed Flare Literature.

    Barker ES, Chiu K, Brown VL, et al.

    The Journal of urology 2024; (211(3)):341-353 doi:10.1097/JU.0000000000003820.

    PMID: 38109700
  76. 76

    Validation of Distinct Bladder Pain Phenotypes Utilizing the MAPP Research Network Cohort.

    Nettey OS, Gu C, Jackson NJ, Ackerman AL

    International urogynecology journal 2024; (35(3)):637-648 doi:10.1007/s00192-024-05735-1.

    PMID: 38300276
  77. 77

    Acute Uncomplicated UTIs in Adults: Rapid Evidence Review.

    Kurotschka PK, Gágyor I, Ebell MH

    American family physician 2024; (109(2)):167-174.

    PMID: 38393801
  78. 78

    d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial.

    Hayward G, Mort S, Hay AD, et al.

    JAMA internal medicine 2024; (184(6)):619-628 doi:10.1001/jamainternmed.2024.0264.

    PMID: 38587819
  79. 79

    The Diagnosis, Treatment, and Prevention of Recurrent Urinary Tract Infection.

    Schmiemann G, Kranz J, Mandraka F, et al.

    Deutsches Arzteblatt international 2024; (121(11)):373-382.

    PMID: 38686602
  80. 80

    Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype.

    Nickel JC, Cotechini T, Doiron RC

    Pathogens (Basel, Switzerland) 2024; (13(5)) doi:10.3390/pathogens13050396.

    PMID: 38787248
  81. 81

    This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndrome.

    Mazza M, Margoni S, Mandracchia G, et al.

    World journal of psychiatry 2024; (14(6)):954-984 doi:10.5498/wjp.v14.i6.954.

    PMID: 38984334
  82. 82

    Nonantibiotic prophylaxis for urinary tract infections: a network meta-analysis of randomized controlled trials.

    Han Z, Yi X, Li J, et al.

    Infection 2025; (53(2)):535-546 doi:10.1007/s15010-024-02357-z.

    PMID: 39095666
  83. 83

    The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome.

    Yu WR, Jhang JF, Jiang YH, Kuo HC

    Biomedicines 2024; (12(9)) doi:10.3390/biomedicines12092051.

    PMID: 39335564
  84. 84

    Dietary Influence on Bladder Pain Syndrome: A Systematic Review.

    Almutairi S

    Cureus 2024; (16(9)):e69437 doi:10.7759/cureus.69437.

    PMID: 39411625
  85. 85

    The Psychosocial Impact of Urinary Dysfunction.

    Gleicher S, Sebesta EM, Dmochowski RR

    Urology research & practice 2024; (50(3)):167-172 doi:10.5152/tud.2024.23217.

    PMID: 39498947
  86. 86

    Pelvic floor muscle pain is associated with higher symptom scores and bladder pain perception in women with interstitial cystitis and bladder pain syndrome.

    Yu WR, Jhang JF, Jiang YH, Kuo HC

    World journal of urology 2024; (43(1)):9 doi:10.1007/s00345-024-05366-7.

    PMID: 39625572
  87. 87

    A Systematic Review of the Prevalence of Overactive Bladder in Women with Non-Urinary Tract Endometriosis and the Effect of Endometriosis Surgery on Symptoms of Overactive Bladder.

    Muriithi FG, Vij M, Mukherjee S, Emery S

    International urogynecology journal 2025; (36(4)):741-748 doi:10.1007/s00192-024-06018-5.

    PMID: 39738854
  88. 88

    State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.

    Advani SD, Thaden JT, Perez R, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025; (80(3)):e31-e42 doi:10.1093/cid/ciae653.

    PMID: 40095960
  89. 89

    Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: Current Limitations and a Pragmatic Clinical Diagnostic Definition.

    Werneburg GT, Moldwin R, Lowell Parsons C, et al.

    Neurourology and urodynamics 2026; (45(1)):32-38 doi:10.1002/nau.70112.

    PMID: 40626422
  90. 90

    Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome.

    Ruetten H, Crawford LK, De EJB, et al.

    Neurourology and urodynamics 2026; (45(1)):54-59 doi:10.1002/nau.70117.

    PMID: 40671333
  91. 91

    Variability in the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Internet Survey.

    Melkonian E, Garrett AL, Kline E, et al.

    JMIR formative research 2025; (9()):e70813 doi:10.2196/70813.

    PMID: 40764047
  92. 92

    Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.

    Buford K, Peters KM, Riedl C, et al.

    Neurourology and urodynamics 2026; (45(1)):46-53 doi:10.1002/nau.70106.

    PMID: 40783827
  93. 93

    Long-Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan.

    Akiyama Y, Hashimoto K, Niimi A, et al.

    International journal of urology : official journal of the Japanese Urological Association 2025; (32(12)):1834-1842 doi:10.1111/iju.70227.

    PMID: 40947757
  94. 94

    Efficacy of D-mannose as prophylaxis of recurrent urinary tract infection: a systematic review and meta-analysis of randomized controlled trials.

    Vargas CEF, Mutarelli A, Menegardo LG, et al.

    Jornal brasileiro de nefrologia 2025; (47(4)):e20250169 doi:10.1590/2175-8239-JBN-2025-0169en.

    PMID: 41004704
  95. 95

    Functional bladder capacity can reflect the bladder condition and treatment outcome in patients with interstitial cystitis/bladder pain syndrome.

    Yu WR, Kuo HC

    World journal of urology 2026; (44(1)):101 doi:10.1007/s00345-025-05937-2.

    PMID: 41546691
  96. 96

    Promoting the Self-Management of Women with IC/BPS: Insights into International Guidelines (Systematic Review).

    Enaux J, Kaiser AV, Kobleder A, Knecht C

    International urogynecology journal 2026; (37(6)):1503-1514 doi:10.1007/s00192-026-06532-8.

    PMID: 41920328
  97. 97

    Update to the management of recurrent urinary tract infections in women aged 16 years and older.

    Sanyaolu L, Ahmed H, Santer M, et al.

    Drug and therapeutics bulletin 2026; (64(8)):116-125 doi:10.1136/dtb.2025.000042.

    PMID: 42044997
  98. 98

    Optimizing the Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: An ESSIC Proposal.

    Malde S, Akiyama Y, Janssen D, et al.

    European urology open science 2026; (89()):32-45 doi:10.1016/j.euros.2026.04.007.

    PMID: 42255254
  99. 99

    Recurrent UTI in Women: Diagnosis and Management.

    Zwahlen D, Ball J, Jackson Q

    American family physician 2026; (113(6)):568-577.

    PMID: 42301870
  100. 100

    Definition and Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome.

    Taneja R

    International journal of urology : official journal of the Japanese Urological Association 2026; (33 Suppl 1()):e70415 doi:10.1111/iju.70415.

    PMID: 42303419
  101. 101

    Clinical Implications of Glomerulation After Cystoscopic Hydrodistention in Patients With Interstitial Cystitis and Bladder Pain Syndrome.

    Yu WR, Jiang YH, Jhang JF, Kuo HC

    International journal of urology : official journal of the Japanese Urological Association 2026; (33 Suppl 1()):e70416 doi:10.1111/iju.70416.

    PMID: 42303446
  102. 102

    Which investigations should be performed after a first episode of urinary tract infection in men?

    Soudais B, Bruyère F, Forestier E, et al.

    Infectious diseases now 2026; (56(6S)):105315 doi:10.1016/j.idnow.2026.105315.

    PMID: 42323088
  103. 103

    Vaginal Estrogen for Urinary Tract Infection Prevention: A Narrative Review of Evidence, Guidelines, and Regulatory Gaps.

    Ghasoub R, Mackay W, Shepherd A

    Gynecologic and obstetric investigation 2026; 1-9 doi:10.1159/000553344.

    PMID: 42378201
  104. 104

    Development and multi-observer validation of a histopathological scoring system for interstitial cystitis/bladder pain syndrome diagnosis.

    Akiyama Y, Malde S, Lako K, et al.

    World journal of urology 2026; (44(1)).

    PMID: 42469462
  105. 105

    Atlas of Hunner's lesions and glomerulations and their correlations with bladder computed tomography findings in patients with interstitial cystitis.

    Lee YS, Jiang YH, Jhang JF, Kuo HC

    International urology and nephrology 2026; doi:10.1007/s11255-026-05278-y.

    PMID: 42521907
  106. 106

    Characterizing the role of the urobiome in the pathogenesis of recurrent urinary tract infections (rUTIs): a systematic review.

    Sheiber J, Duque A, Ranjan A, et al.

    International urology and nephrology 2026; doi:10.1007/s11255-026-05317-8.

    PMID: 42573928